A longitudinal follow-up study of the quantification of dopamine transporters with 123I-Ioflupane (DaTscan)

[1]  Klaus Tatsch,et al.  Nigrostriatal Dopamine Terminal Imaging with Dopamine Transporter SPECT: An Update , 2013, The Journal of Nuclear Medicine.

[2]  J. Darcourt,et al.  Automatic semi-quantification of [123I]FP-CIT SPECT scans in healthy volunteers using BasGan version 2: results from the ENC-DAT database , 2013, European Journal of Nuclear Medicine and Molecular Imaging.

[3]  Koen Van Laere,et al.  EANM procedure guidelines for brain neurotransmission SPECT using 123I-labelled dopamine transporter ligands, version 2 , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[4]  Pierre Payoux,et al.  Iterative three-dimensional expectation maximization restoration of single photon emission computed tomography images: application in striatal imaging. , 2005, Medical physics.

[5]  Irène Buvat,et al.  Quantitative accuracy of dopaminergic neurotransmission imaging with (123)I SPECT. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  S. Reeves,et al.  Ageing and the nigrostriatal dopaminergic system , 2002, International journal of geriatric psychiatry.

[7]  A. Chantraine,et al.  Maladie de Parkinson , 2013 .

[8]  K. Laere,et al.  European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[9]  J. Seibyl,et al.  Age-related decline in dopamine transporters: analysis of striatal subregions, nonlinear effects, and hemispheric asymmetries. , 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[10]  M. Zanca.  Marquage scintigraphique des récepteurs dopaminergiques D2 et des sites de transport de la dopamine: méthodologie et techniques de quantification , 2002 .

[11]  J. Esquerré,et al.  Tomoscintigraphie et neurotransmission dopaminergique: apport dans l'exploration des syndromes extrapyramidaux , 2002 .